Rare diseases
Investigational molecules
Locations
Back to Hungary83 clinical trials in Szekszard, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease
HungaryStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
HungaryStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
HungaryStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
HungaryStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
HungaryEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
HungaryA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
HungaryEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
HungaryHungaryComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
HungaryStudy of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
HungaryStudy Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
HungaryThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on non-small cell lung cancer and advanced breast cancer treatments. Studies evaluate novel combination therapies including eftilagimod alfa and innovative approaches for treating various stages of cancer.
Research includes investigations of targeted therapies and immunotherapy combinations for improved patient outcomes.
Extensive research into inflammatory bowel diseases, with multiple trials examining new treatments for Crohn's Disease and ulcerative colitis. Novel therapies include obefazimod and mirikizumab studies.
Focus on developing treatments for patients with moderate to severe disease activity.
Important studies addressing heart failure and stroke prevention. Trials evaluate medications like asundexian for atrial fibrillation and new approaches for cardiovascular disease management.
Research emphasizes long-term cardiovascular outcomes and preventive strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
